Table IV. Cancer-Related Predictors of Life Partnership/Marriage in CCS in Two Logistic Multivariable Models.

	Life partnershipa			Marriagea
	ORb	95% CI	P-valuec	ORb	95% CI	P-valuec
Diagnosis (ICCC-3)
Leukemia	1.00			1.00
Lymphoma	0.94	0.64–1.40		1.04	0.59–1.81
CNS	0.23	0.12–0.41		0.43	0.18–1.08
Neuroblastoma	0.64	0.30–1.33		1.13	0.34–3.75
Retinoblastoma	0.52	0.19–1.43		0.56	0.07–4.52
Renal tumor	1.29	0.71–2.33		0.86	0.31–2.34
Hepatic tumor	0.96	0.16–5.59		1.41	0.13–15.27
Bone tumor	1.25	0.68–2.31		2.01	0.85–4.71
Soft tissue sarcoma	1.49	0.79–2.78		0.97	0.41–2.30
Germ cell tumor	0.56	0.24–1.29		0.78	0.23–2.62
Langerhans cell histiocytosis	0.84	0.41–1.74	<0.001	1.31	0.46–3.67	0.601
Treatmentd
Chemotherapy	1.00			1.00
Radiotherapy	0.76	0.55–1.05		0.86	0.54–1.36
Surgery	1.90	1.03–3.49		1.19	0.45–3.13
Bone marrow transplantation	0.79	0.38–1.64	0.018	0.38	0.09–1.53	0.501
Age at diagnosis (in years)
0–5	1.00			1.00
>5–10	1.08	0.75–1.55		1.06	0.62–1.82
>10–16	1.12	0.78–1.62	0.826	1.03	0.60–1.77	0.979
Relapse
No	1.00			1.00
Yes	0.83	0.54–1.27	0.387	0.52	0.26–1.04	0.064

CNS, central nervous system; ICCC-3, International Classification of Childhood Cancer—Third Edition [25].

^aStandardized on age, gender, migration, language region, and educational level;

^bOdds ratio (OR) for marriage and life partnership;

^cGlobal P-value calculated with Wald test;

^dChemotherapy may include surgery; radiotherapy: may include surgery and/or chemotherapy; bone marrow transplantation: may include surgery, chemotherapy, and/or radiotherapy.